GB201505393D0 - Antimicrobal peptide formulations - Google Patents

Antimicrobal peptide formulations

Info

Publication number
GB201505393D0
GB201505393D0 GBGB1505393.7A GB201505393A GB201505393D0 GB 201505393 D0 GB201505393 D0 GB 201505393D0 GB 201505393 A GB201505393 A GB 201505393A GB 201505393 D0 GB201505393 D0 GB 201505393D0
Authority
GB
United Kingdom
Prior art keywords
antimicrobal
peptide formulations
peptide
formulations
antimicrobal peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1505393.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SECR DEFENCE
UK Secretary of State for Defence
Original Assignee
SECR DEFENCE
UK Secretary of State for Defence
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SECR DEFENCE, UK Secretary of State for Defence filed Critical SECR DEFENCE
Priority to GBGB1505393.7A priority Critical patent/GB201505393D0/en
Publication of GB201505393D0 publication Critical patent/GB201505393D0/en
Priority to EP16712396.7A priority patent/EP3277261A1/en
Priority to PCT/GB2016/000058 priority patent/WO2016156772A1/en
Priority to GB1604893.6A priority patent/GB2541483B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Birds (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1505393.7A 2015-03-30 2015-03-30 Antimicrobal peptide formulations Ceased GB201505393D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GBGB1505393.7A GB201505393D0 (en) 2015-03-30 2015-03-30 Antimicrobal peptide formulations
EP16712396.7A EP3277261A1 (en) 2015-03-30 2016-03-22 Antimicrobial peptide formulations
PCT/GB2016/000058 WO2016156772A1 (en) 2015-03-30 2016-03-22 Antimicrobial peptide formulations
GB1604893.6A GB2541483B (en) 2015-03-30 2016-03-23 Antimicrobial peptide formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1505393.7A GB201505393D0 (en) 2015-03-30 2015-03-30 Antimicrobal peptide formulations

Publications (1)

Publication Number Publication Date
GB201505393D0 true GB201505393D0 (en) 2015-05-13

Family

ID=53178319

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1505393.7A Ceased GB201505393D0 (en) 2015-03-30 2015-03-30 Antimicrobal peptide formulations
GB1604893.6A Active GB2541483B (en) 2015-03-30 2016-03-23 Antimicrobial peptide formulations

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB1604893.6A Active GB2541483B (en) 2015-03-30 2016-03-23 Antimicrobial peptide formulations

Country Status (3)

Country Link
EP (1) EP3277261A1 (en)
GB (2) GB201505393D0 (en)
WO (1) WO2016156772A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3120348A1 (en) 2018-11-19 2020-05-28 Octet Medical, Inc. Device, systems, and methods of applying a treatment solution to a treatment site
CN113318054A (en) * 2021-05-10 2021-08-31 上海高庄生物科技有限公司 Cosmetic antiseptic composition and preparation method thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001060162A2 (en) * 2000-02-15 2001-08-23 Ohio University Cationic, amphipathic beta-sheet peptides and uses thereof
US20050282755A1 (en) * 2004-03-18 2005-12-22 Ansata Therapeutics, Inc. Compositions having antimicrobial activity and uses thereof
US7745390B2 (en) * 2005-05-23 2010-06-29 The Board Of Trustees Of The Leland Stanford Junior University Antimicrobial peptides
WO2006128289A1 (en) * 2005-06-02 2006-12-07 University Of Manitoba Use of brevinin-2r in the treatment of cancer
JP4942084B2 (en) * 2005-11-24 2012-05-30 学校法人順天堂 Apoptosis inhibitor
EP1925664A1 (en) * 2006-11-15 2008-05-28 Scil proteins GmbH Artificial binding proteins based on a modified alpha helical region of ubiquitin
GB0703945D0 (en) * 2007-03-01 2007-04-11 Univ Bristol Peptide
CN102091319B (en) * 2011-01-14 2012-11-07 哈尔滨工业大学 Use of toad peptide antibiotic for preparing medicaments for treating herpes zoster
US8530409B1 (en) * 2012-06-12 2013-09-10 Dipexium Pharmaceuticals LLC Stable pexiganan formulation

Also Published As

Publication number Publication date
WO2016156772A1 (en) 2016-10-06
GB2541483B (en) 2019-04-17
EP3277261A1 (en) 2018-02-07
GB201604893D0 (en) 2016-05-04
GB2541483A (en) 2017-02-22

Similar Documents

Publication Publication Date Title
IL273541A (en) Formulations
IL273282A (en) Niraparib formulations
IL269630A (en) Niraparib formulations
IL269621A (en) Niraparib formulations
SI4070788T1 (en) Pharmaceutical formulations
SG10201607915YA (en) Cleaning formulations
IL265609A (en) Novel formulations
IL256491A (en) Pharmaceutical formulations
GB201607918D0 (en) Novel formulations
GB201419091D0 (en) Formulations
GB201419261D0 (en) Formulations
IL258570A (en) Stable protein compositions
ZA201707094B (en) Pharmaceutical formulations
PT3316856T (en) Blended formulations
GB201505393D0 (en) Antimicrobal peptide formulations
GB201805338D0 (en) Cosmetic formulations
GB201621277D0 (en) Formulations
GB201714461D0 (en) Formulations
GB201618110D0 (en) Formulations
GB201616366D0 (en) Formulations
GB201615754D0 (en) Formulations
GB201507784D0 (en) Formulations
GB201505532D0 (en) Formulations
GB201617866D0 (en) Novel formulations
GB201616509D0 (en) Novel formulations

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)